Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study
Autore:
Lyon, MR; Cline, JC; de Zepetnek, JT; Shan, JJ; Pang, P; Benishin, C;
Indirizzi:
Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada Univ Alberta Edmonton AB Canada T6G 2H7 iol, Edmonton, AB T6G 2H7, Canada CV Technol, Edmonton, AB, Canada CV Technol Edmonton AB CanadaCV Technol, Edmonton, AB, Canada Oceanside Funct Med Res Inst, Nanaimo, BC, Canada Oceanside Funct Med Res Inst Nanaimo BC Canada Inst, Nanaimo, BC, Canada
Titolo Testata:
JOURNAL OF PSYCHIATRY & NEUROSCIENCE
fascicolo: 3, volume: 26, anno: 2001,
pagine: 221 - 228
SICI:
1180-4882(200105)26:3<221:EOTHEC>2.0.ZU;2-6
Fonte:
ISI
Lingua:
ENG
Soggetto:
HEALTHY-VOLUNTEERS; COGNITION; DEMENTIA; DOPAMINE; EGB-761; RATS; ADHD;
Keywords:
alternative medicine; attention deficit disorder with hyperactivity; Ginkgo biloba; ginseng; medicine; herbal; treatment outcome;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Citazioni:
32
Recensione:
Indirizzi per estratti:
Indirizzo: Benishin, C Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada Univ Alberta Edmonton AB Canada T6G 2H7 n, AB T6G 2H7, Canada
Citazione:
M.R. Lyon et al., "Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study", J PSYCH NEU, 26(3), 2001, pp. 221-228

Abstract

Objective: A combination herbal product containing American ginseng extract, Panax quinquefolium, (200 mg) and Ginkgo biloba extract (50 mg) (AD-FX; CV Technologies, Edmonton, Alta.) was tested for its ability to improve thesymptoms of attention-deficit hyperactivity disorder (ADHD). Design: Open study. Patients: 36 children ranging in age from 3 to 17 years who fit the diagnostic criteria for ADHD. Interventions: AD-FX capsules were taken twice a day on an empty stomach for 4 weeks. Patients were instructed not to change any other medications during the study. Outcome measures: At the beginning of the study, after 2 weeks, and then at the end of the 4-week trial, parents completed the Conners' Parent Rating Scale - revised, long version,a questionnaire that assesses a broad range of problem behaviours (and wasused as an indication of ADHD symptom severity). Results: After 2 weeks oftreatment, the proportion of the subjects exhibiting improvement (i.e., decrease in T-score of at least 5 points) ranged from 31% for the anxious-shyattribute to 67% for the psychosomatic attribute. After 4 weeks of treatment, the proportion of subjects exhibiting improvement ranged from 44% for the social problems attribute to 74% for the Conners' ADHD index and the DSM-IV hyperactive-impulsive attribute. Five (14%) of 36 subjects reported adverse events, only 2 of which were considered related to the study medication. Conclusions: These preliminary results suggest AD-FX treatment may improve symptoms of ADHD and should encourage further research on the use of ginseng and Ginkgo biloba extracts to treat ADHD symptoms.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/20 alle ore 12:54:42